Home » Newsletters » BioWorld Science

BioWorld Science

March 24, 2005

View Archived Issues

Eisai and TorreyPines collaborate on Alzheimer's drug development

Genentech and Ipsen to develop sustained-release human growth hormone

PT-141 reported to increase the efficacy of sildenafil in ED

Kaken Pharmaceutical and Chiron sign bFGF license agreement

Gilead signs JTK-303 licensing agreement

Biovitrum to acquire Cambridge Biotechnology

Microscience's typhoid vaccine program boosted by Wellcome Trust award

GSK licensees Theravance's MABA program

Roche studies Pegasys and Copegus to treat HCV in liver transplant patients

TB Alliance and GlaxoSmithKline team up in tuberculosis fight

SinusPharma changes name to Naryx Pharma

Xyrem sNDA accepted for review

Second milestone in Actelion and Merck's renin alliance

GOG initiates phase III study of Xyotax in ovarian cancer

Antigen Express advances AE-37 into clinical studies in breast cancer

Positive data from phase I studies of PGCvax

CAT terminates further glaucoma development of Trabio

Gemcitabine-cardiolipin conjugate more potent and less toxic than gemcitabine in preclinical tests

Merck conducting active research of mGluR2 agonists

H3/H4 receptor antagonist modulates IgE and NO production in vitro

Neovastat markedly reduces inflammation and hyperresponsiveness in asthma model

TACE inhibitor shows promise for the treatment of TNF-alpha-mediated diseases

Orally active p38alpha MAPK inhibitors effective in preclinical model of arthritis / News in Context

New clinical data on pramipexole in restless legs syndrome reported

Ropinirole demonstrates efficacy in restless legs syndrome

SR-142801 produces mixed results in panic disorder trial

TP-10 aids recovery in lung transplant patients

Antiasthma effects of AVP-13358 via a novel mechanism of distribution of protein trafficking

Patents covering treatments for pain disclosed

Roche reports agents for the treatment of diabetes

New treatments for obesity described in patent literature

FK-778 improves experimental cardiac graft survival

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...